Učitavanje...
Auranofin, at clinically achievable dose, protects mice and prevents recurrence from Clostridioides difficile infection
Clostridioides difficile is the leading cause of nosocomial infections and a worldwide urgent public health threat. Without doubt, there is an urgent need for new effective anticlostridial agents due to the increasing incidence and severity of C. difficile infection (CDI). The aim of the present stu...
Spremljeno u:
| Izdano u: | Sci Rep |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Nature Publishing Group UK
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7206065/ https://ncbi.nlm.nih.gov/pubmed/32382070 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-64882-9 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|